Global Irbesartan Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 112
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Combination Drugs

- Prescribed Drugs

Segment by Application

- Hyperlipidemia

- High Blood Pressure

- Heart Failure

- Kidney Disease

- Fibrous Fibrillation

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Teva

- Sanofi

- BMS

- Sumitomo Dainippon Pharma

- Novartis

- Shionogi

- Hanall

- Taj Pharmaceuticals

- Apotex

- Jiangsu Hengrui Medicine

- Verdant Life Sciences

- Angita Pharma

- Auro Pharma

- Avanstra

- Zhuhai Rundu Pharma

- Xiansheng Pharmaceutical

- CTTQ

- Tianjin Huairen Pharmaceutical

- Jiangsu Wangao Pharmaceutical

- Zhejiang Huahai Pharmaceutical

- Zhejiang Ainuo Pharmaceutical

- Yuanhe Pharmaceutical

Global Irbesartan Market Research Report 2022

Table of Contents
1 Irbesartan Market Overview
1.1 Product Overview and Scope of Irbesartan
1.2 Irbesartan Segment by Type
1.2.1 Global Irbesartan Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Irbesartan Segment by Application
1.3.1 Global Irbesartan Sales Comparison by Application: (2022-2028)
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Global Irbesartan Market Size Estimates and Forecasts
1.4.1 Global Irbesartan Revenue 2017-2028
1.4.2 Global Irbesartan Sales 2017-2028
1.4.3 Irbesartan Market Size by Region: 2017 Versus 2021 Versus 2028
2 Irbesartan Market Competition by Manufacturers
2.1 Global Irbesartan Sales Market Share by Manufacturers (2017-2022)
2.2 Global Irbesartan Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Irbesartan Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Irbesartan Manufacturing Sites, Area Served, Product Type
2.5 Irbesartan Market Competitive Situation and Trends
2.5.1 Irbesartan Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Irbesartan Players Market Share by Revenue
2.5.3 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Irbesartan Retrospective Market Scenario by Region
3.1 Global Irbesartan Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Irbesartan Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Irbesartan Market Facts & Figures by Country
3.3.1 North America Irbesartan Sales by Country
3.3.2 North America Irbesartan Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Irbesartan Market Facts & Figures by Country
3.4.1 Europe Irbesartan Sales by Country
3.4.2 Europe Irbesartan Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Irbesartan Market Facts & Figures by Region
3.5.1 Asia Pacific Irbesartan Sales by Region
3.5.2 Asia Pacific Irbesartan Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Irbesartan Market Facts & Figures by Country
3.6.1 Latin America Irbesartan Sales by Country
3.6.2 Latin America Irbesartan Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Irbesartan Market Facts & Figures by Country
3.7.1 Middle East and Africa Irbesartan Sales by Country
3.7.2 Middle East and Africa Irbesartan Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Irbesartan Historic Market Analysis by Type
4.1 Global Irbesartan Sales Market Share by Type (2017-2022)
4.2 Global Irbesartan Revenue Market Share by Type (2017-2022)
4.3 Global Irbesartan Price by Type (2017-2022)
5 Global Irbesartan Historic Market Analysis by Application
5.1 Global Irbesartan Sales Market Share by Application (2017-2022)
5.2 Global Irbesartan Revenue Market Share by Application (2017-2022)
5.3 Global Irbesartan Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Teva Irbesartan Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Irbesartan Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BMS
6.3.1 BMS Corporation Information
6.3.2 BMS Description and Business Overview
6.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.3.4 BMS Irbesartan Product Portfolio
6.3.5 BMS Recent Developments/Updates
6.4 Sumitomo Dainippon Pharma
6.4.1 Sumitomo Dainippon Pharma Corporation Information
6.4.2 Sumitomo Dainippon Pharma Description and Business Overview
6.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sumitomo Dainippon Pharma Irbesartan Product Portfolio
6.4.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novartis Irbesartan Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Shionogi
6.6.1 Shionogi Corporation Information
6.6.2 Shionogi Description and Business Overview
6.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Shionogi Irbesartan Product Portfolio
6.6.5 Shionogi Recent Developments/Updates
6.7 Hanall
6.6.1 Hanall Corporation Information
6.6.2 Hanall Description and Business Overview
6.6.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hanall Irbesartan Product Portfolio
6.7.5 Hanall Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Corporation Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Taj Pharmaceuticals Irbesartan Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Apotex Irbesartan Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Jiangsu Hengrui Medicine Irbesartan Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Verdant Life Sciences
6.11.1 Verdant Life Sciences Corporation Information
6.11.2 Verdant Life Sciences Irbesartan Description and Business Overview
6.11.3 Verdant Life Sciences Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Verdant Life Sciences Irbesartan Product Portfolio
6.11.5 Verdant Life Sciences Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Corporation Information
6.12.2 Angita Pharma Irbesartan Description and Business Overview
6.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Angita Pharma Irbesartan Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Auro Pharma
6.13.1 Auro Pharma Corporation Information
6.13.2 Auro Pharma Irbesartan Description and Business Overview
6.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Auro Pharma Irbesartan Product Portfolio
6.13.5 Auro Pharma Recent Developments/Updates
6.14 Avanstra
6.14.1 Avanstra Corporation Information
6.14.2 Avanstra Irbesartan Description and Business Overview
6.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Avanstra Irbesartan Product Portfolio
6.14.5 Avanstra Recent Developments/Updates
6.15 Zhuhai Rundu Pharma
6.15.1 Zhuhai Rundu Pharma Corporation Information
6.15.2 Zhuhai Rundu Pharma Irbesartan Description and Business Overview
6.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Zhuhai Rundu Pharma Irbesartan Product Portfolio
6.15.5 Zhuhai Rundu Pharma Recent Developments/Updates
6.16 Xiansheng Pharmaceutical
6.16.1 Xiansheng Pharmaceutical Corporation Information
6.16.2 Xiansheng Pharmaceutical Irbesartan Description and Business Overview
6.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Xiansheng Pharmaceutical Irbesartan Product Portfolio
6.16.5 Xiansheng Pharmaceutical Recent Developments/Updates
6.17 CTTQ
6.17.1 CTTQ Corporation Information
6.17.2 CTTQ Irbesartan Description and Business Overview
6.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.17.4 CTTQ Irbesartan Product Portfolio
6.17.5 CTTQ Recent Developments/Updates
6.18 Tianjin Huairen Pharmaceutical
6.18.1 Tianjin Huairen Pharmaceutical Corporation Information
6.18.2 Tianjin Huairen Pharmaceutical Irbesartan Description and Business Overview
6.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio
6.18.5 Tianjin Huairen Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Wangao Pharmaceutical
6.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
6.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Description and Business Overview
6.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio
6.19.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.20 Zhejiang Huahai Pharmaceutical
6.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Description and Business Overview
6.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio
6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Ainuo Pharmaceutical
6.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
6.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Description and Business Overview
6.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio
6.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
6.22 Yuanhe Pharmaceutical
6.22.1 Yuanhe Pharmaceutical Corporation Information
6.22.2 Yuanhe Pharmaceutical Irbesartan Description and Business Overview
6.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Yuanhe Pharmaceutical Irbesartan Product Portfolio
6.22.5 Yuanhe Pharmaceutical Recent Developments/Updates
7 Irbesartan Manufacturing Cost Analysis
7.1 Irbesartan Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Irbesartan
7.4 Irbesartan Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Irbesartan Distributors List
8.3 Irbesartan Customers
9 Irbesartan Market Dynamics
9.1 Irbesartan Industry Trends
9.2 Irbesartan Market Drivers
9.3 Irbesartan Market Challenges
9.4 Irbesartan Market Restraints
10 Global Market Forecast
10.1 Irbesartan Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Irbesartan by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Irbesartan by Type (2023-2028)
10.2 Irbesartan Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Irbesartan by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Irbesartan by Application (2023-2028)
10.3 Irbesartan Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Irbesartan by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Irbesartan by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Irbesartan Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Irbesartan Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Irbesartan Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Irbesartan Market Competitive Situation by Manufacturers in 2021
Table 5. Global Irbesartan Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Irbesartan Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Irbesartan Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Irbesartan Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Irbesartan Average Price (US$/G) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Irbesartan Manufacturing Sites and Area Served
Table 11. Manufacturers Irbesartan Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Irbesartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irbesartan as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Irbesartan Sales by Region (2017-2022) & (KG)
Table 16. Global Irbesartan Sales Market Share by Region (2017-2022)
Table 17. Global Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Irbesartan Revenue Market Share by Region (2017-2022)
Table 19. North America Irbesartan Sales by Country (2017-2022) & (KG)
Table 20. North America Irbesartan Sales Market Share by Country (2017-2022)
Table 21. North America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Irbesartan Revenue Market Share by Country (2017-2022)
Table 23. Europe Irbesartan Sales by Country (2017-2022) & (KG)
Table 24. Europe Irbesartan Sales Market Share by Country (2017-2022)
Table 25. Europe Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Irbesartan Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Irbesartan Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Irbesartan Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Irbesartan Revenue Market Share by Region (2017-2022)
Table 31. Latin America Irbesartan Sales by Country (2017-2022) & (KG)
Table 32. Latin America Irbesartan Sales Market Share by Country (2017-2022)
Table 33. Latin America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Irbesartan Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Irbesartan Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Irbesartan Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Irbesartan Revenue Market Share by Country (2017-2022)
Table 39. Global Irbesartan Sales by Type (2017-2022) & (KG)
Table 40. Global Irbesartan Sales Market Share by Type (2017-2022)
Table 41. Global Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Irbesartan Revenue Share by Type (2017-2022)
Table 43. Global Irbesartan Price by Type (2017-2022) & (US$/G)
Table 44. Global Irbesartan Sales (KG) by Application (2017-2022)
Table 45. Global Irbesartan Sales Market Share by Application (2017-2022)
Table 46. Global Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Irbesartan Revenue Share by Application (2017-2022)
Table 48. Global Irbesartan Price by Application (2017-2022) & (US$/G)
Table 49. Teva Corporation Information
Table 50. Teva Description and Business Overview
Table 51. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 52. Teva Irbesartan Product
Table 53. Teva Recent Developments/Updates
Table 54. Sanofi Corporation Information
Table 55. Sanofi Description and Business Overview
Table 56. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 57. Sanofi Irbesartan Product
Table 58. Sanofi Recent Developments/Updates
Table 59. BMS Corporation Information
Table 60. BMS Description and Business Overview
Table 61. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 62. BMS Irbesartan Product
Table 63. BMS Recent Developments/Updates
Table 64. Sumitomo Dainippon Pharma Corporation Information
Table 65. Sumitomo Dainippon Pharma Description and Business Overview
Table 66. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 67. Sumitomo Dainippon Pharma Irbesartan Product
Table 68. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 69. Novartis Corporation Information
Table 70. Novartis Description and Business Overview
Table 71. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 72. Novartis Irbesartan Product
Table 73. Novartis Recent Developments/Updates
Table 74. Shionogi Corporation Information
Table 75. Shionogi Description and Business Overview
Table 76. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 77. Shionogi Irbesartan Product
Table 78. Shionogi Recent Developments/Updates
Table 79. Hanall Corporation Information
Table 80. Hanall Description and Business Overview
Table 81. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 82. Hanall Irbesartan Product
Table 83. Hanall Recent Developments/Updates
Table 84. Taj Pharmaceuticals Corporation Information
Table 85. Taj Pharmaceuticals Description and Business Overview
Table 86. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 87. Taj Pharmaceuticals Irbesartan Product
Table 88. Taj Pharmaceuticals Recent Developments/Updates
Table 89. Apotex Corporation Information
Table 90. Apotex Description and Business Overview
Table 91. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 92. Apotex Irbesartan Product
Table 93. Apotex Recent Developments/Updates
Table 94. Jiangsu Hengrui Medicine Corporation Information
Table 95. Jiangsu Hengrui Medicine Description and Business Overview
Table 96. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 97. Jiangsu Hengrui Medicine Irbesartan Product
Table 98. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 99. Verdant Life Sciences Corporation Information
Table 100. Verdant Life Sciences Description and Business Overview
Table 101. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 102. Verdant Life Sciences Irbesartan Product
Table 103. Verdant Life Sciences Recent Developments/Updates
Table 104. Angita Pharma Corporation Information
Table 105. Angita Pharma Description and Business Overview
Table 106. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 107. Angita Pharma Irbesartan Product
Table 108. Angita Pharma Recent Developments/Updates
Table 109. Auro Pharma Corporation Information
Table 110. Auro Pharma Description and Business Overview
Table 111. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 112. Auro Pharma Irbesartan Product
Table 113. Auro Pharma Recent Developments/Updates
Table 114. Avanstra Corporation Information
Table 115. Avanstra Description and Business Overview
Table 116. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 117. Avanstra Irbesartan Product
Table 118. Avanstra Recent Developments/Updates
Table 119. Zhuhai Rundu Pharma Corporation Information
Table 120. Zhuhai Rundu Pharma Description and Business Overview
Table 121. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 122. Zhuhai Rundu Pharma Irbesartan Product
Table 123. Zhuhai Rundu Pharma Recent Developments/Updates
Table 124. Xiansheng Pharmaceutical Corporation Information
Table 125. Xiansheng Pharmaceutical Description and Business Overview
Table 126. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 127. Xiansheng Pharmaceutical Irbesartan Product
Table 128. Xiansheng Pharmaceutical Recent Developments/Updates
Table 129. CTTQ Corporation Information
Table 130. CTTQ Description and Business Overview
Table 131. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 132. CTTQ Irbesartan Product
Table 133. CTTQ Recent Developments/Updates
Table 134. Tianjin Huairen Pharmaceutical Corporation Information
Table 135. Tianjin Huairen Pharmaceutical Description and Business Overview
Table 136. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 137. Tianjin Huairen Pharmaceutical Irbesartan Product
Table 138. Tianjin Huairen Pharmaceutical Recent Developments/Updates
Table 139. Jiangsu Wangao Pharmaceutical Corporation Information
Table 140. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 141. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 142. Jiangsu Wangao Pharmaceutical Irbesartan Product
Table 143. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 144. Zhejiang Huahai Pharmaceutical Corporation Information
Table 145. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 146. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 147. Zhejiang Huahai Pharmaceutical Irbesartan Product
Table 148. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 149. Zhejiang Ainuo Pharmaceutical Corporation Information
Table 150. Zhejiang Ainuo Pharmaceutical Description and Business Overview
Table 151. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 152. Zhejiang Ainuo Pharmaceutical Irbesartan Product
Table 153. Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
Table 154. Yuanhe Pharmaceutical Corporation Information
Table 155. Yuanhe Pharmaceutical Description and Business Overview
Table 156. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 157. Yuanhe Pharmaceutical Irbesartan Product
Table 158. Yuanhe Pharmaceutical Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Irbesartan Distributors List
Table 162. Irbesartan Customers List
Table 163. Irbesartan Market Trends
Table 164. Irbesartan Market Drivers
Table 165. Irbesartan Market Challenges
Table 166. Irbesartan Market Restraints
Table 167. Global Irbesartan Sales Forecast by Type (2023-2028) & (KG)
Table 168. Global Irbesartan Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Irbesartan Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Irbesartan Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Irbesartan Sales Forecast by Application (2023-2028) & (KG)
Table 172. Global Irbesartan Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Irbesartan Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Irbesartan Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Irbesartan Sales Forecast by Region (2023-2028) & (KG)
Table 176. Global Irbesartan Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Irbesartan Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Irbesartan Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Irbesartan
Figure 2. Global Irbesartan Market Share by Type in 2021 & 2028
Figure 3. Combination Drugs Product Picture
Figure 4. Prescribed Drugs Product Picture
Figure 5. Global Irbesartan Market Share by Application in 2021 & 2028
Figure 6. Hyperlipidemia
Figure 7. High Blood Pressure
Figure 8. Heart Failure
Figure 9. Kidney Disease
Figure 10. Fibrous Fibrillation
Figure 11. Other
Figure 12. Global Irbesartan Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Irbesartan Market Size (2017-2028) & (US$ Million)
Figure 14. Global Irbesartan Sales (2017-2028) & (KG)
Figure 15. Irbesartan Sales Share by Manufacturers in 2021
Figure 16. Global Irbesartan Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Irbesartan Players: Market Share by Revenue in 2021
Figure 18. Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Irbesartan Sales Market Share by Region (2017-2022)
Figure 20. Global Irbesartan Sales Market Share by Region in 2021
Figure 21. Global Irbesartan Revenue Market Share by Region (2017-2022)
Figure 22. Global Irbesartan Revenue Market Share by Region in 2021
Figure 23. U.S. Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. UAE Irbesartan Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Irbesartan by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Irbesartan
Figure 49. Manufacturing Process Analysis of Irbesartan
Figure 50. Irbesartan Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Irbesartan Market Research Report 2022
    Published: 03-Aug-2022        Price: US 2900 Onwards        Pages: 112
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Combination Drugs - Prescribed Drugs Segment by Application - Hyperlipidemia - High B......
  • Global Metoprolol Tartrate Market Research Report 2022
    Published: 20-Jul-2022        Price: US 2900 Onwards        Pages: 89
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral - Injectable Segment by Application - Hypertension - Cardiovascular Diseases......
  • Global Pulmonary Arterial Hypertension (PAH) Market Research Report 2022
    Published: 30-Jun-2022        Price: US 2900 Onwards        Pages: 82
    Pulmonary Arterial Hypertension (PAH) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pulmonary Arterial Hypertension (PAH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Prostacyclin and Prostacyclin Analogs - S......
  • Global Amlodipine Besilate Market Research Report 2022
    Published: 28-Jun-2022        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Purity=98% - Purity=99% ......
  • Global and United States Clonidine Market Report & Forecast 2022-2028
    Published: 17-Jun-2022        Price: US 4350 Onwards        Pages: 116
    Clonidine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Clonidine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Clonidine market size by players, by Type and by Application, f......
  • Global and United States Pulmonary Arterial Hypertension (PAH) Medicine Market Report & Forecast 2022-2028
    Published: 17-Jun-2022        Price: US 4350 Onwards        Pages: 90
    Pulmonary Arterial Hypertension (PAH) Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pulmonary Arterial Hypertension (PAH) Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focu......
  • Global and United States Antihypertensive Drugs Market Report & Forecast 2022-2028
    Published: 17-Jun-2022        Price: US 4350 Onwards        Pages: 109
    Antihypertensive Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Antihypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Antihypertensive Drugs market size by......
  • Global and United States Pulmonary Arterial Hypertension (PAH) Market Report & Forecast 2022-2028
    Published: 14-Jun-2022        Price: US 4350 Onwards        Pages: 90
    Pulmonary Arterial Hypertension (PAH) market is segmented By Region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pulmonary Arterial Hypertension (PAH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast By Region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on......
  • Global and United States Indapamide Market Report & Forecast 2022-2028
    Published: 09-Jun-2022        Price: US 4350 Onwards        Pages: 102
    Indapamide market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Indapamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Indapamide market size by players, by Type and by App......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs